AMEH - Apollo Medical Holdings Inc


Moderate Growth and Stable


based on last 5 year data.
Income Statement is MODERATE
Revenue Growth is 33.25%
Operating Income Growth is -45.33%
Net Income Growth is 122.04%
Earnings Per Share (EPS) Growth is 136.0%
Net Margin is 3.24%
Balance Sheet is MODERATE
Current Asset to Current Liability Ratio is 2.5
Debt Ratio is 0.5
Current Debt to Net Income Ratio is 1.35
Total Debt to Total Assets Ratio is 0.29
Cash Flow is MODERATE
Cash from Operations turning Positive
Capital Expenditure is Low
Net Increase in Cash is Positive
Long Term Score Trend is NEUTRAL
Investment Risk is Low
based on last 4 quarter data.
Unless specified, all values are in USD Millions. Data extracted from SEC Filing and are subject to processing and input errors.
Apollo Medical Holdings Inc (AMEH) -
ApolloMed is a leading physician-centric, technology-enabled healthcare management company. Leveraging its proprietary population health management and healthcare delivery platform, ApolloMed operates an integrated, value-based healthcare model, which aims to empower the providers in its network to deliver the highest quality of care to its patients in a cost-effective manner.
Industry - Dental Laboratories
Sector - Manufacturing

Disclaimer - Investment in securities involves substantial risk and could result in significant loss. It is not suitable for every investor. Before acting on information on this website, you should consider whether it is suitable for your particular circumstances and strongly consider seeking advice from your own financial or investment adviser. We may own some of the securities mentioned in this website.
Know the Stock © 2021 and future.